Agios Pharma (AGIO) Reports In-Line Q2 EPS

Agios Pharma (NASDAQ: AGIO) reported Q2 EPS of ($1.41), in-line with the analyst estimate of ($1.41).

For earnings history and earnings-related data on Agios Pharma (AGIO) click here.

You May Also Be Interested In

• Meta AI agent ‘Muse’ triggers massive tech rally as chips and Wall Street soar
• AI and earnings keep driving markets as focus shifts to Trump-Xi summit
• Here Group posts FY2026 results with $88M revenue, goodwill write-down